PVLA · Palvella Therapeutics, Inc.
AI read · Good for PVLA
The AI's read
A third program gives Palvella another chance to develop a treatment for a rare skin disease. The presentation lists early studies and an IND filing as plans, not completed steps. No trial results or approval are reported, so this is an early step, but it adds another possible treatment to develop.